Tradiational vision exams such as the visual acuity chart, undergone by hundreds of millions of patients worldwide every year, are manual, subjective, time-consuming and dependent on the examiner’s abilities and experience.
When performed on children, traditional vision exams may be inaccurate when not performed properly, mainly for young children who can’t always cooperate with the examiner’s instructions or communicate what they’re seeing. This may result in frustration and loss of cooperation with the patient, leading to undetected or misdiagnosed vision impairments. Though traditional eye exams can be accurate when thoroughly performed, they are time consuming and require significant effort for the eye care provider.
Tradiational vision exams such as the visual acuity chart, undergone by hundreds of millions of patients worldwide every year, are manual, subjective, time-consuming and dependent on the examiner’s abilities and experience.
When performed on children, traditional vision exams might be inaccurate when not performed properly, mainly for young children who can’t always cooperate with the examiner’s instructions or communicate what they’re seeing. This may result with frustration and loss of cooperation with the patient leading to undetected or misdiagnosed vision impairments.
Digital and automated eye examination is a relatively new approach in vision care. It is based on digital technologies for accurate and objective measurements while identifying visual disorders.
Novel digital and automated vision testing devices require minimal patient cooperation. The tests are fast, accurate, and objective. Since these devices are simple to use, they can be operated by any trained individual at a hospital, clinic, or even at the optic store.
In order to improve the efficiency and accuracy of vision exams and offer a more comprehensive set of vision exams, NovaSight has developed the EyeSwift®, followed by its second-generation device, the EyeSwift®PRO, which is a comprehensive, eye-tracking-based vision diagnostic system.
© 2022 NovaSight | All Rights Reserved | NS-00779-R08
CureSight™ and EyeSwift®PRO devices are CE marked in accordance with EU Medical Device Regulation 2017/745.
CureSight™ is an FDA 510(K) cleared device.
Caution: The EyeSwift®PRO system is an Investigational Device, Limited By Federal (Or United States) Law To Investigational Use.
Currently, TrackSightTM is not approved for sales in any country.
Your data will be handled in accordance with our Privacy
Policy. In the event that a child’s or minor’s information is
being submitted as part of this form, we hereby request
that such information be submitted solely by the legal
guardian of such child or minor.
Your data will be handled in accordance with our Privacy
Policy. In the event that a child’s or minor’s information is
being submitted as part of this form, we hereby request
that such information be submitted solely by the legal
guardian of such child or minor.
This website uses cookies for functional, operational, analytical and advertising purposes. Please review our Privacy Policy for more information
